<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07340035500346</udiDi>
    <basicUdiDi>B-07340035500346</basicUdiDi>
    <tradeName>07340035500346</tradeName>
    <deviceName>SSP DRB1*14</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.117-12u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:55.706Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500322</udiDi>
    <basicUdiDi>B-07340035500322</basicUdiDi>
    <tradeName>07340035500322</tradeName>
    <deviceName>SSP DRB1*13</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.116-03u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:54.815Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500308</udiDi>
    <basicUdiDi>B-07340035500308</basicUdiDi>
    <tradeName>07340035500308</tradeName>
    <deviceName>SSP DRB1*13</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.116-24u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:50.576Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500285</udiDi>
    <basicUdiDi>B-07340035500285</basicUdiDi>
    <tradeName>07340035500285</tradeName>
    <deviceName>SSP DRB1*11</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.115-03u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:48.850Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500261</udiDi>
    <basicUdiDi>B-07340035500261</basicUdiDi>
    <tradeName>07340035500261</tradeName>
    <deviceName>SSP DRB1*11</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.115-24u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:48.070Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500247</udiDi>
    <basicUdiDi>B-07340035500247</basicUdiDi>
    <tradeName>07340035500247</tradeName>
    <deviceName>SSP DRB1*04</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.114-03u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:47.245Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500223</udiDi>
    <basicUdiDi>B-07340035500223</basicUdiDi>
    <tradeName>07340035500223</tradeName>
    <deviceName>SSP DRB1*04</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.114-24u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:43.242Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500209</udiDi>
    <basicUdiDi>B-07340035500209</basicUdiDi>
    <tradeName>07340035500209</tradeName>
    <deviceName>SSP DRB1*03</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.113-04u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:42.441Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500186</udiDi>
    <basicUdiDi>B-07340035500186</basicUdiDi>
    <tradeName>07340035500186</tradeName>
    <deviceName>SSP DRB1*03</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.113-24u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:41.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500162</udiDi>
    <basicUdiDi>B-07340035500162</basicUdiDi>
    <tradeName>07340035500162</tradeName>
    <deviceName>SSP DRB1*16</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.126-12u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:40.842Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500148</udiDi>
    <basicUdiDi>B-07340035500148</basicUdiDi>
    <tradeName>07340035500148</tradeName>
    <deviceName>SSP DRB1*15</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.125-06u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:36.041Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500124</udiDi>
    <basicUdiDi>B-07340035500124</basicUdiDi>
    <tradeName>07340035500124</tradeName>
    <deviceName>SSP DRB1*15</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.125-24u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:35.244Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500100</udiDi>
    <basicUdiDi>B-07340035500100</basicUdiDi>
    <tradeName>07340035500100</tradeName>
    <deviceName>SSP DRB1*01</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.111-06u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:34.440Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500087</udiDi>
    <basicUdiDi>B-07340035500087</basicUdiDi>
    <tradeName>07340035500087</tradeName>
    <deviceName>SSP DRB1*01</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.111-24u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:33.645Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500049</udiDi>
    <basicUdiDi>B-07340035500049</basicUdiDi>
    <tradeName>07340035500049</tradeName>
    <deviceName>SSP DR low</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.101-12u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:30.618Z</lastUpdated>
  </row>
  <row>
    <udiDi>07340035500025</udiDi>
    <basicUdiDi>B-07340035500025</basicUdiDi>
    <tradeName>07340035500025</tradeName>
    <deviceName>SSP DR low</deviceName>
    <manufacturerName>CareDx AB</manufacturerName>
    <manufacturerSrn>SE-MF-000040995</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Ek II Liste B</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030403</emdnCode>
    <emdnDescription>HLA ANTIGEN TYPING</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>101.101-48u</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-07T01:06:29.385Z</lastUpdated>
  </row>
  <row>
    <udiDi>06976019890168</udiDi>
    <basicUdiDi>B-06976019890168</basicUdiDi>
    <tradeName>Human Leukocyte Antigen (HLA) Genotyping Kit (Single-Molecule Nanopore Strand Sequencing)</tradeName>
    <deviceName>Human Leukocyte Antigen (HLA) Genotyping Kit (Single-Molecule Nanopore Strand Sequencing)</deviceName>
    <manufacturerName>Qitan Taike Biotechnology Ltd., Chengdu</manufacturerName>
    <manufacturerSrn>CN-MF-000040515</manufacturerSrn>
    <authorisedRepresentativeName>MedPath GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000087</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030499</emdnCode>
    <emdnDescription>TISSUE TYPING REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>OS006011</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-06T21:26:33.587Z</lastUpdated>
  </row>
  <row>
    <udiDi>06974968583216</udiDi>
    <basicUdiDi>B-06974968583216</basicUdiDi>
    <tradeName>Human Papillomavirus (HPV) Typing Detection Kit ( Reversible Terminator Sequencing)</tradeName>
    <deviceName>Human Papillomavirus (HPV) Typing Detection Kit ( Reversible Terminator Sequencing)</deviceName>
    <manufacturerName>GeneMind Biosciences Co., Ltd.</manufacturerName>
    <manufacturerSrn>CN-MF-000025785</manufacturerSrn>
    <authorisedRepresentativeName>Umedwings Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000444</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>IVDD</legislation>
    <emdnCode>W01030499</emdnCode>
    <emdnDescription>TISSUE TYPING REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>L000047</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-07-06T18:07:53.023Z</lastUpdated>
  </row>
  <row>
    <udiDi>05999565781316</udiDi>
    <basicUdiDi>599956578001TV</basicUdiDi>
    <tradeName>NanoTYPE 96/11 CE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Omixon Biocomputing Ltd.</manufacturerName>
    <manufacturerSrn>HU-MF-000003018</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W01030499</emdnCode>
    <emdnDescription>TISSUE TYPING REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NT9611CE</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-06T03:20:13.682Z</lastUpdated>
  </row>
  <row>
    <udiDi>05999565781323</udiDi>
    <basicUdiDi>599956578001TV</basicUdiDi>
    <tradeName>NanoTYPE 4x96/11 CE</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Omixon Biocomputing Ltd.</manufacturerName>
    <manufacturerSrn>HU-MF-000003018</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>W01030499</emdnCode>
    <emdnDescription>TISSUE TYPING REAGENTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NT4x9611CE</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-06T03:20:13.659Z</lastUpdated>
  </row>
</eudamedExport>